BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 21841252)

  • 1. Gender-dependent transthyretin modulation of brain amyloid-β levels: evidence from a mouse model of Alzheimer's disease.
    Oliveira SM; Ribeiro CA; Cardoso I; Saraiva MJ
    J Alzheimers Dis; 2011; 27(2):429-39. PubMed ID: 21841252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model.
    Ribeiro CA; Oliveira SM; Guido LF; Magalhães A; Valencia G; Arsequell G; Saraiva MJ; Cardoso I
    J Alzheimers Dis; 2014; 39(2):357-70. PubMed ID: 24169237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible involvement of transthyretin in hippocampal beta-amyloid burden and learning behaviors in a mouse model of Alzheimer's disease (TgCRND8).
    Doggui S; Brouillette J; Chabot JG; Farso M; Quirion R
    Neurodegener Dis; 2010; 7(1-3):88-95. PubMed ID: 20173334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transthyretin and Alzheimer's disease: where in the brain?
    Sousa JC; Cardoso I; Marques F; Saraiva MJ; Palha JA
    Neurobiol Aging; 2007 May; 28(5):713-8. PubMed ID: 16698124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric expression patterns of brain transthyretin in normal mice and a transgenic mouse model of Alzheimer's disease.
    Tsai KJ; Yang CH; Lee PC; Wang WT; Chiu MJ; Shen CK
    Neuroscience; 2009 Mar; 159(2):638-46. PubMed ID: 19167467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human serum transthyretin levels correlate inversely with Alzheimer's disease.
    Han SH; Jung ES; Sohn JH; Hong HJ; Hong HS; Kim JW; Na DL; Kim M; Kim H; Ha HJ; Kim YH; Huh N; Jung MW; Mook-Jung I
    J Alzheimers Dis; 2011; 25(1):77-84. PubMed ID: 21335655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
    J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease.
    Wati H; Kawarabayashi T; Matsubara E; Kasai A; Hirasawa T; Kubota T; Harigaya Y; Shoji M; Maeda S
    Brain Pathol; 2009 Jan; 19(1):48-57. PubMed ID: 18429966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotection in early stages of Alzheimer's disease is promoted by transthyretin angiogenic properties.
    Gião T; Saavedra J; Vieira JR; Pinto MT; Arsequell G; Cardoso I
    Alzheimers Res Ther; 2021 Aug; 13(1):143. PubMed ID: 34429155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid beta peptide levels.
    Pacheco-Quinto J; Rodriguez de Turco EB; DeRosa S; Howard A; Cruz-Sanchez F; Sambamurti K; Refolo L; Petanceska S; Pappolla MA
    Neurobiol Dis; 2006 Jun; 22(3):651-6. PubMed ID: 16516482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer's disease.
    Amtul Z; Wang L; Westaway D; Rozmahel RF
    Neuroscience; 2010 Aug; 169(2):781-6. PubMed ID: 20493928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model.
    Yue X; Lu M; Lancaster T; Cao P; Honda S; Staufenbiel M; Harada N; Zhong Z; Shen Y; Li R
    Proc Natl Acad Sci U S A; 2005 Dec; 102(52):19198-203. PubMed ID: 16365303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated Abeta deposition in APPswe/PS1deltaE9 mice with hemizygous deletions of TTR (transthyretin).
    Choi SH; Leight SN; Lee VM; Li T; Wong PC; Johnson JA; Saraiva MJ; Sisodia SS
    J Neurosci; 2007 Jun; 27(26):7006-10. PubMed ID: 17596449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: implications for Alzheimer beta-amyloid pathology.
    Maynard CJ; Cappai R; Volitakis I; Cherny RA; Masters CL; Li QX; Bush AI
    J Inorg Biochem; 2006 May; 100(5-6):952-62. PubMed ID: 16574231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment with lithium alleviates memory deficits and reduces amyloid-β production in an aged Alzheimer's disease transgenic mouse model.
    Zhang X; Heng X; Li T; Li L; Yang D; Zhang X; Du Y; Doody RS; Le W
    J Alzheimers Dis; 2011; 24(4):739-49. PubMed ID: 21321394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model.
    Cardoso I; Saraiva MJ
    FASEB J; 2006 Feb; 20(2):234-9. PubMed ID: 16449795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5Alpha-dihydrotestosterone up-regulates transthyretin levels in mice and rat choroid plexus via an androgen receptor independent pathway.
    Quintela T; Alves CH; Gonçalves I; Baltazar G; Saraiva MJ; Santos CR
    Brain Res; 2008 Sep; 1229():18-26. PubMed ID: 18634756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transthyretin participates in beta-amyloid transport from the brain to the liver--involvement of the low-density lipoprotein receptor-related protein 1?
    Alemi M; Gaiteiro C; Ribeiro CA; Santos LM; Gomes JR; Oliveira SM; Couraud PO; Weksler B; Romero I; Saraiva MJ; Cardoso I
    Sci Rep; 2016 Feb; 6():20164. PubMed ID: 26837706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Treatment with Iododiflunisal Delays Hippocampal Amyloid-β Formation in a Transgenic Mouse Model of Alzheimer's Disease: A Longitudinal in vivo Molecular Imaging Study1.
    Rejc L; Gómez-Vallejo V; Rios X; Cossío U; Baz Z; Mujica E; Gião T; Cotrina EY; Jiménez-Barbero J; Quintana J; Arsequell G; Cardoso I; Llop J
    J Alzheimers Dis; 2020; 77(1):99-112. PubMed ID: 32804152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.